CN117085078A - 一种治疗斑秃的外用中药组合物及制备方法与应用 - Google Patents
一种治疗斑秃的外用中药组合物及制备方法与应用 Download PDFInfo
- Publication number
- CN117085078A CN117085078A CN202311275796.7A CN202311275796A CN117085078A CN 117085078 A CN117085078 A CN 117085078A CN 202311275796 A CN202311275796 A CN 202311275796A CN 117085078 A CN117085078 A CN 117085078A
- Authority
- CN
- China
- Prior art keywords
- parts
- alopecia areata
- chinese medicine
- traditional chinese
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000004631 alopecia areata Diseases 0.000 title claims abstract description 62
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims description 10
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 9
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 9
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 9
- 240000002924 Platycladus orientalis Species 0.000 claims abstract description 9
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 9
- 241001643642 Viticis Species 0.000 claims abstract description 9
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 9
- 240000004510 Agastache rugosa Species 0.000 claims abstract description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 8
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 8
- 241000931143 Gleditsia sinensis Species 0.000 claims abstract description 8
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 8
- 241000951473 Schizonepeta Species 0.000 claims abstract description 8
- 240000003377 Shepherdia canadensis Species 0.000 claims abstract description 8
- 235000018324 Shepherdia canadensis Nutrition 0.000 claims abstract description 8
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 3
- 210000004209 hair Anatomy 0.000 claims description 34
- 210000004761 scalp Anatomy 0.000 claims description 22
- 238000002791 soaking Methods 0.000 claims description 12
- 210000003128 head Anatomy 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 241001529821 Agastache Species 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 241000606266 Nardostachys Species 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000006072 paste Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000000344 soap Substances 0.000 claims description 4
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 claims description 3
- 241000219784 Sophora Species 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000007888 film coating Substances 0.000 claims description 3
- 238000009501 film coating Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000011505 plaster Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000009736 wetting Methods 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 208000003251 Pruritus Diseases 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 230000007803 itching Effects 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 201000004384 Alopecia Diseases 0.000 description 20
- 231100000360 alopecia Toxicity 0.000 description 17
- 238000003745 diagnosis Methods 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 230000010415 tropism Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 8
- 241000219304 Portulacaceae Species 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 4
- 208000001840 Dandruff Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010001766 Alopecia totalis Diseases 0.000 description 2
- 206010001767 Alopecia universalis Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
- 108010036949 Cyclosporine Proteins 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000032775 alopecia universalis congenita Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229930182912 cyclosporin Natural products 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019670 Hepatic function abnormal Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 235000009001 Quillaja saponaria Nutrition 0.000 description 1
- 241001162994 Rugosus Species 0.000 description 1
- 241000694414 Sapindus saponaria Species 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 208000030695 Sparse hair Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- HCIBTBXNLVOFER-UHFFFAOYSA-N diphenylcyclopropenone Chemical compound O=C1C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 HCIBTBXNLVOFER-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229960002311 dithranol Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000003741 hair volume Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- -1 plasters Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 235000008113 selfheal Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- XBRWELTXMQSEIN-UHFFFAOYSA-N squaric acid dibutyl ester Chemical compound CCCCOC1=C(OCCCC)C(=O)C1=O XBRWELTXMQSEIN-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
本发明公开一种治疗斑秃的外用中药组合物,涉及斑秃治疗技术领域。所述治疗斑秃的中药组合物,由以下重量份数的原料组成:艾叶1‑3份、皂角1‑3份、无患子1‑3、薄荷1‑2份、防风1‑2份、藿香1‑2份、甘松1‑2份、侧柏叶1‑2份、荆芥1‑2份、蔓荆子1‑2、苦参1‑2份、马齿苋1‑3份。本发明治疗斑秃的外用中药组合物,组合物采用纯中药原料制备,无毒无副作用,能活血祛风止痒,高效治疗斑秃,适合推广应用。
Description
技术领域
本发明涉及一种治疗斑秃的中药组合物及制备方法与应用,涉及斑秃治疗技术领域。
背景技术
斑秃(alopecia areata,AA)是临床上最常见慢性脱发类的疾病之一,主要的临床表现为局限性、非瘢痕性的脱发斑,患者本身无自觉症状,严重者可进展成全秃(alopeciatotalis,AT)和普秃(alopecia universalis,AU)。典型的临床表现包括突然出现的以圆形为主、边界清晰、直径1~10cm、数目不等的脱发区,脱发处皮肤光滑,无炎症、鳞屑和瘢痕,绝大多数患者可自愈,也有少数严重患者,迁延不愈,亦可发展为全秃或普秃。2009年研究表明,我国斑秃的患病率为0.27%。已有报道报道脱发可以降低患者的生活质量,并引起多种心理问题,包括及焦虑、自卑、过度自我关注等。斑秃是临床上常见的脱发疾病之一,在各个年龄段均有发病(发明人诊治过最小患者仅132岁),在许多病例中,无论治疗还是未治疗患者,疾病都经常复发。目前西医对于AA的治疗方法主要集中在自身免疫方面。该病具有不同的治疗选择,包括局部疗法和全身疗法。局部治疗主要是使用糖皮质激素、接触性致敏剂(例如方行酸二丁酯(SADBE)和二苯环丙烯酮(DPCP)),米诺地尔、地蒽酚;全身治疗主要是甲氨蝶呤、环孢素、激酶抑制剂、复方甘草酸苷。但都未被证明长期有效,需考虑每种疗法可能的副作用。例如:局部使用糖皮质激素常期会导致毛囊炎、皮肤萎缩变薄及毛细血管扩张。目前已报道成人接触性致敏剂的成功率为50%~60%,且不能用于儿童。现在市场上比较流行的米诺地尔是目前来说效果好,不良反应少的一种药,但仍然会引起使用2周后脱发增加的现象。在系统性使用药物里,甲氨蝶呤会导致肝功能损害、胃肠道反应、感染等。环孢素使用剂量过大或时间过长容易出现肾毒性、神经毒性等。
AA的发病机制及确切的病理学改变尚不完全清楚,但据报道可能与特定区域免役特权系统崩溃有关,治疗有一定的难度。该病给患者带来严重的心理负担及经济负担,所以其疗法及机制仍需要探索。
祖国医学认为发为血之余,肝主藏血,肝血瘀滞或肝血不足都会引起血不能上达巅顶濡养头发,又复因风邪外袭,风性开泄而导致毛发脱落形成斑秃。中医中药立足于整体观念,在脱发尤其是斑秃的治疗方面,具有疗效好、无毒副作用独特的优势。
因此,申请人提供一种治疗斑秃的外用中药组合物,能祛风止痒,治疗斑秃。
发明内容
本发明的目的在于提供一种治疗斑秃的外用中药组合物及制备方法与应用,组合物采用纯中药原料制备,无毒无副作用,能活血祛风止痒,高效治疗斑秃,适合推广应用。
为实现上述技术目的,达到上述技术效果,本发明是通过以下技术方案实现:
一种治疗斑秃的中药组合物,由以下重量份数的原料组成:艾叶1-3份、皂角1-3份、无患子1-3、薄荷1-2份、防风1-2份、藿香1-2份、甘松1-2份、侧柏叶1-2份、荆芥1-2份、蔓荆子1-2份、苦参1-2份、马齿苋1-3份。
进一步的,所述治疗斑秃的中药组合物,由以下重量份数的原料组成:艾叶3份、皂角3份、无患子2份、薄荷1份、防风2份、藿香1份、甘松1份、侧柏叶1份、荆芥1份、蔓荆子1份、苦参1份、马齿苋1份。
本发明的另一目的在于,提供一种治疗斑秃的中药组合物的制备方法;
所述制备方法为:
S1:按比例取皂角、无患子用冷水浸泡30min得到浸泡液;
S2:按比例取艾叶、薄荷、防风、藿香、甘松、侧柏叶、荆芥、蔓荆子、苦参、马齿苋粉碎、过筛、混合倒入S1得到的浸泡液中混合均匀,得到预处理后的原料混合液;
S3:将S2得到的原料混合物加热至沸腾,并保持15-20min,过滤掉液体中的残渣并适当浓缩,得到浓缩液;
S4:将S3得到的浓缩液冷却至常温后,常温密封保存。
进一步的,所述S2还包括按比例取艾叶、薄荷、防风、藿香、甘松、侧柏叶、荆芥、蔓荆子、苦参、马齿苋研碎包煎倒入浸泡液。
本发明的另一目的在于,提供一种治疗斑秃的中药组合物的使用方法;
所述使用方法包括:
取浓缩液将头皮及头发淋湿,并按摩熏洗患处或整个头部3-5min,再用温水冲洗干净即可;每日一次或者隔日一次。
本发明的另一目的在于,提供一种治疗斑秃的中药组合物的应用;
所述治疗斑秃的外用中药组合物,可制备为药皂、溶液、酊剂、和醑剂、粉剂、洗剂、油剂、软膏、糊剂、硬膏、涂膜剂、凝胶、气雾剂,作为治疗斑秃使用。
本发明的中药组合物是参照君、臣、佐、使的中药组方原则所设计的现代中药,采用的原料药的功效如下所述:
艾叶:性味归经:苦、辛,温。功效:温经止血,散寒止痛。
薄荷:性味归经:辛,凉。功效:发散风热、清利头目,利咽,透疹止痒。
防风:性味归经:辛、甘,微温。功效:祛风解表,胜湿止痛,解痉。
甘松:性味归经:辛、甘,温。功效:行气化湿,开郁醒脾。
藿香:性味归经:辛、微温。功效:化湿解表。
侧柏叶:性味归经:苦、涩,微寒。功效:凉血止血,祛痰止咳。《本草易读》:“灭瘢痕而生肌,润鬓发而黑头”。
荆芥:性味归经:辛、微温。功效:祛风解表,透疹,止血。
蔓荆子:性味归经:辛、苦,微寒。功效:疏散风热,清利头目,止痛。
苦参:性味归经:苦、寒。功效:清热燥湿,杀虫。
马齿苋:性味归经:酸,寒。功效:去寒热,杀虫,破癥结、痈疮。
皂角:性味归经:性温,味辛、咸。有小毒。功效:祛风逐痰,利九窍,通关节,治头风,杀诸虫精物,消谷,导痰。
无患子:又名洗手果、肥皂树。苦、微辛,寒。有小毒。功效:清热除痰,利咽止泻。
本发明的治疗斑秃的中药组合物,其中艾叶活血温经通络,改善头皮血液循环作用改善头皮的血液循环,为君药;薄荷、防风、荆芥、蔓荆子均既可祛风止痒,又作为引经药使药物直达头部;藿香、甘松除湿,可以改善头皮出油过多情况;苦参、马齿苋有良好的杀虫作用,即现代医血的抗菌消炎作用,改善头皮生态。侧柏叶促进新发再生。皂角和无患子均含有丰富的皂苷成分,在本方中起到良好的清洁毛发即头皮的作用,其中皂角也可以作为引经药,加强以上诸药祛风逐痰,通利头皮的作用,从而改善头皮血液循环,促使新发再生。
本发明的有益效果:
本发明的治疗斑秃的中药组合物,为纯中药组合物构成的外用药物,使用安全,无毒无副作用;
本发明的治疗斑秃的中药组合物,对于斑秃有很好的疗效,且能有效缩短治疗疗程,降低复发率;本发明的治疗斑秃的中药组合物,对于脂溢性脱发及头皮屑亦又很好的改善效果;可制备为药皂、溶液、酊剂、和醑剂、粉剂、洗剂、油剂、软膏、糊剂、硬膏、涂膜剂、凝胶、气雾剂,作为治疗斑秃、脂溢性脱发及头皮屑治疗使用;
本发明可以清洁头发头皮,在达到活血祛风止痒、促进新发再生的情况下,不再需要其他清洁产品,可最大限度发挥药效,且有效预防化工类产品造成的脱发情况。
当然,实施本发明的任一产品并不一定需要同时达到以上所述的所有优点。
附图说明
图1为本发明实施例2所述典型病例1的实际效果图;
图2为本发明实施例2所述典型病例2的实际效果图;
图3为本发明实施例2所述典型病例3的实际效果图;
图4为本发明实施例2所述典型病例4的实际效果图;
图5为本发明实施例2所述典型病例5的实际效果图;
图6为本发明实施例2所述典型病例6的实际效果图;
具体实施方式
为了更清楚地说明本发明实施例的技术方案,下面将结合实施例对本发明进行详细说明。
实施例1
一种治疗斑秃的中药组合物,由以下重量份数的原料组成:艾叶3份、皂角3份、无患子2份、薄荷1份、防风2份、藿香1份、甘松1份、侧柏叶1份、荆芥1份、蔓荆子1份、苦参1份、马齿苋1份。
所述制备方法为:
S1:按比例取皂角、无患子用冷水浸泡30min得到浸泡液;
S2:按比例取艾叶、薄荷、防风、藿香、甘松、侧柏叶、荆芥、蔓荆子、苦参、马齿苋粉碎、过筛、混合倒入S1得到的浸泡液中混合均匀,得到预处理后的原料混合液;
S3:将S2得到的原料混合物加热至沸腾,并保持15-20min,过滤掉液体中的残渣并适当浓缩,得到浓缩液;
S4:将S3得到的浓缩液冷却至常温后,常温密封保存。
所述S2还包括按比例取艾叶、薄荷、防风、藿香、甘松、侧柏叶、荆芥、蔓荆子、苦参、马齿苋研碎包煎倒入浸泡液。
实施例2
典型病例:
病例1:
金某,女,12岁。2021年12月25日首诊。就诊时脱发已2月余,近1周脱发突然加重,导致头发仅剩很少量,头皮基本裸露在外,头皮瘙痒。头皮颜色苍白,毛囊明显萎缩。平素纳差,较同龄孩子瘦小。予上方外用熏洗,配合内服中药。2021年2月4日复诊,可见毛囊情况较前明显好转,已有新发长出,长出新发又黑又粗。但头皮未完全覆盖。2021年4月5日复诊。患者新发长出,已完全覆盖头皮,头发黑亮,较脱发前头发更浓密。(如图1)
病例2:
王某,男33岁。2021年7月15日首诊。就诊时斑秃半年,半年前患者突然出现斑秃,以头顶处斑秃为主,伴有头皮出油较多及瘙痒情况。平素容易发作过敏性疾病,睡眠差。予上方外用配合中药汤剂内服。2021年8月10复诊。斑秃处已又新发长出,可见清晰发根,且之前少量白发转黑。头皮瘙痒及出油明显改善。2021年9月10日复诊。患者斑秃基本恢复,虽然发量稍显稀疏,但无裸露头皮。
病例3:
赵某某,女,34岁。2021年6月20日首诊。患者头顶斑秃半年余,脱发后十分焦虑,经常入睡困难,或梦多易醒。予上方外用,配合中药内服。2021年7月10日复诊。患者头发已明显可见清晰发根,发根已大致布满患处,因患者新生头发及原发长短不一,建议患者剔光头后重新蓄发,继续给予中药外用兼内服。2021年9月10日,患者头发已基本长出,已基本能覆盖头皮,发量恢复脱发之前,继续给予中药外用兼内服。2021年10月4日。患者斑秃痊愈,且新生头发较患者脱发前头发更黑更浓密,光泽感好。
病例4:
李某,女,30岁。2021年4月25日首诊。斑秃1月,理发时由理发师发现,位于后枕部,患处头皮苍白。发病前4个月来入睡困难,梦多,工作压力大。予上方外用及中药内服。2021年5月11日复诊,由少量新生头发长出,偶有头皮及上至皮肤瘙痒不适,予上方外用及中药内服。2021年6月15日复诊。斑秃愈,新发已完全覆盖头皮。
病例5
唐某,女,33岁,2022年3曰18日就诊。患者斑秃1年余,教师职业,平素操心较多,经常失眠,入睡困难,夜梦多,伴有四肢关节酸胀疼痛,天冷时加重。1年前开始出现脱发,导致后颈部上方大面积斑秃,就诊时可见部分大量萎缩。予上方外用及中药内服。2022年3月25日复诊,可见颈部上方斑秃患处中间开始长出新生黑白相间头发,继续给予上方外用及中药内服。5月20日复诊,斑秃面积肉眼可见缩小。6月10复诊,新生毛发部位进一步扩大,继续给予上方中药外用及中药内服。
病例6
马某,202年8月25日就诊。斑秃3月,患者3月前无明显诱因下出现斑秃,理发时发现。平素常有失眠,焦虑情况,入睡困难严重,近3月来基本凌晨1-2时方可入睡,舌质有裂纹,无舌苔。常觉颈部及枕部疼痛。予中药内服及以上方外用熏洗,2021年11月18日复诊,斑秃处长出新生头发,新发基本覆盖原斑秃处。后患者因工作较忙均未复诊,2022年1月微信询问患者斑秃情况,诉斑秃已愈,并发照片如下。
实施例5
本发明的治疗斑秃的中药组合物,添加以医学上可接受的辅料,采用现有的制备工艺,将其制备为药皂、溶液、酊剂、和醑剂、粉剂、洗剂、油剂、软膏、糊剂、硬膏、涂膜剂、凝胶、气雾剂,作为治疗斑秃、脂溢性脱发及头皮屑治疗使用;
也可以作为添加剂添加在现有的产品。
在本说明书的描述中,参考术语“一个实施例”、“示例”、“具体示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施例或示例中以合适的方式结合。
以上公开的本发明优选实施例只是用于帮助阐述本发明。优选实施例并没有详尽叙述所有的细节,也不限制该发明仅为所述的具体实施方式。显然,根据本说明书的内容,可作很多的修改和变化。本说明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和实际应用,从而使所属技术领域技术人员能很好地理解和利用本发明。本发明仅受权利要求书及其全部范围和等效物的限制。
Claims (6)
1.一种治疗斑秃的中药组合物,其特征在于:由以下重量份数的原料组成:艾叶1-3份、皂角1-3份、无患子1-3、薄荷1-2份、防风1-2份、藿香1-2份、甘松1-2份、侧柏叶1-2份、荆芥1-2份、蔓荆子1-2份、苦参1-2份、马齿苋1-3份。
2.如权利要求1所述的治疗斑秃的中药组合物,其特征在于:所述治疗斑秃的中药组合物,由以下重量份数的原料组成:艾叶3份、皂角3份、无患子2份、薄荷1份、防风2份、藿香1份、甘松1份、侧柏叶1份、荆芥1份、蔓荆子1份、苦参1份、马齿苋1份。
3.一种治疗斑秃的中药组合物的制备方法,其特征在于:
所述制备方法为:
S1:按比例取皂角、无患子用冷水浸泡30min得到浸泡液;
S2:按比例取艾叶、薄荷、防风、藿香、甘松、侧柏叶、荆芥、蔓荆子、苦参、马齿苋粉碎、过筛、混合倒入S1得到的浸泡液中混合均匀,得到预处理后的原料混合液;
S3:将S2得到的原料混合物加热至沸腾,并保持15-20min,过滤掉液体中的残渣并适当浓缩,得到浓缩液;
S4:将S3得到的浓缩液冷却至常温后,常温密封保存。
4.如权利要求3所述的治疗斑秃的中药组合物的制备方法,其特征在于:所述S2还包括按比例取艾叶、薄荷、防风、藿香、甘松、侧柏叶、荆芥、蔓荆子、苦参、马齿苋研碎包煎倒入浸泡液。
5.一种治疗斑秃的中药组合物的使用方法,其特征在于:
所述使用方法包括:
取浓缩液将头皮及头发淋湿,并按摩熏洗患处或整个头部3-5min,再用温水冲洗干净即可;每日一次或者隔日一次。
6.一种如权利要求1所述的治疗斑秃的中药组合物的应用,其特征在于:
所述治疗斑秃的外用中药组合物,可制备为药皂、溶液、酊剂、和醑剂、粉剂、洗剂、油剂、软膏、糊剂、硬膏、涂膜剂、凝胶、气雾剂,作为治疗斑秃使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311275796.7A CN117085078A (zh) | 2023-09-28 | 2023-09-28 | 一种治疗斑秃的外用中药组合物及制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311275796.7A CN117085078A (zh) | 2023-09-28 | 2023-09-28 | 一种治疗斑秃的外用中药组合物及制备方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117085078A true CN117085078A (zh) | 2023-11-21 |
Family
ID=88770043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311275796.7A Withdrawn CN117085078A (zh) | 2023-09-28 | 2023-09-28 | 一种治疗斑秃的外用中药组合物及制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117085078A (zh) |
-
2023
- 2023-09-28 CN CN202311275796.7A patent/CN117085078A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705883B (zh) | 一种治疗皮肤病的药物与制备 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103393760A (zh) | 一种治疗鼻炎的外用药物 | |
CN101204529A (zh) | 治疗疮伤和消瘢的药物 | |
CN1079152A (zh) | 一种速效骨伤灵的制备方法 | |
KR20100079858A (ko) | 천연광물과 한약재를 주원료로 한 피부질환 치료용 외용제 | |
CN101396528B (zh) | 一种治疗风热感冒的中药复方制剂 | |
CN104873446A (zh) | 一种含肉桂油的牙膏 | |
CN106421392A (zh) | 一种治疗褥疮的中药凝胶剂及其制备方法 | |
CN117085078A (zh) | 一种治疗斑秃的外用中药组合物及制备方法与应用 | |
CN110051719B (zh) | 一种透骨草和侧柏叶混合提取物及其提取工艺与应用 | |
CN113350419A (zh) | 一种生发固发中药组合物、制备方法及其应用 | |
CN102631406A (zh) | 一种口腔溃疡漱口水 | |
CN106822300B (zh) | 一种祛痘美颜的中药制剂 | |
CN103948709B (zh) | 一种维吾尔药热合美康宫栓剂及其制备方法 | |
CN110946903B (zh) | 用于防治系统性硬化病的中药组合物及其应用 | |
CN115429859B (zh) | 治疗皮肤瘙痒性疾病的中药组合物及其制备方法、用途 | |
CN114159536B (zh) | 药物组合物及其制备方法和应用 | |
CN110882270B (zh) | 一种含有硅基再生医学材料的药物组合物及其制备方法 | |
CN110013513B (zh) | 一种治疗风湿骨痛的外用凝胶及其制备方法 | |
CN1262300C (zh) | 治疗脚气的药水 | |
CN106902286B (zh) | 一种治疗婴幼儿湿疹的中药组合物、其制备方法及应用 | |
CN118252886A (zh) | 一种具有改善皮肤瘙痒的外用草本精华液 | |
CN102813854B (zh) | 一种治疗粉刺的中药膏 | |
CN105663959A (zh) | 一种用于护理牙痛患者的中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20231121 |
|
WW01 | Invention patent application withdrawn after publication |